- Description
-
Details
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established CV disease - Additional Information
-
Additional Information
LENSES-POWER
N/A
SHAPES
N/A
Brands
No
Size
2 PEN
Is Featured
No
Directions of use
Once a day, at any time, independent of meals. Victoza® does not require resuspension and can be injected in the abdomen, thigh, or upper arm with the NovoFine®
Active Ingredients
liraglutide
Indication
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of major adverse cardiovascular (CV) events (
Skin Type
No
Label
No
Show Label
No
Show Offer Homepage
N/A
- Reviews